Resultados de la búsqueda 11-20 of 5638 for Phase

1. Hematología - Ensayos clínicos - Mayo Clinic

   The study will include a Phase 1 part to determine the recommended dose of JCAR017 monotherapy in subjects with relapsed or refractory CLL or SLL, followed by a ...

2. Hematología - Ensayos clínicos - Mayo Clinic

   The study will include a Phase 1 part to determine the recommended dose of JCAR017 monotherapy in subjects with relapsed or refractory CLL or SLL, followed by a ...

3. Cirugía - Ensayos clínicos - Mayo Clinic

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

9. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...